|
Interim results from an ongoing clinical trial of NECVAX-NEO1 highlight its
safety and immunogenicity. These results are NEC's first... Cancer vaccine, Clinical trial, European Society for Medical Oncology, Immuno-Oncology, Oncology, Oral cancer, Vaccine |
|
| More about this | ||
|
|
||
| ||